用于高效性炎症癌症治疗的炎症检查点的生物直角干扰
Wenting Zhang1,2, Zhengwei Liu1,2, Jiawei Zhu1,2
1Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
Journal of the American Chemical Society
|July 24, 2023
概括
这项研究引入了一种新型的纳米调节器,可在癌细胞中触发热死 (编程细胞死亡),同时抑制自身死,这是一种保护机制. 这种双重作用增强了热癌症治疗的疗效和安全性.
科学领域:
- 生物医学工程
- 癌症治疗
- 纳米技术
背景情况:
- 炎症导致的细胞死亡, 显示出治疗癌症的潜力.
- 自作为癌细胞的关键检查点和生存机制,限制了热的疗效.
- 破坏癌细胞的自我保护是增强基于热的疗法的关键.
研究的目的:
- 在癌症治疗中开发一种生物直角纳米调节剂,用于诱导热和克服自介导的抗性.
- 研究纳米调节器在触发热和抑制自检查点方面的双重作用.
主要方法:
- 构建一个仿生,癌细胞膜涂层的纳米调节器.
- 在现场的线粒体合成光敏剂PpIX以产生活性氧物种 (ROS) 并诱导热死.
- 用催化生物对角化学在位生成自抑制剂以破坏热检查点.
主要成果:
- 通过产生线粒体ROS, 纳米调节器成功诱导了热.
- 在现场生成的自抑制剂有效地破坏了热检查点,提高了治疗效果.
- 仿生涂层确保了癌细胞的特异性,最大限度地减少了对正常组织的伤害,证明了安全有效的抗瘤治疗.
结论:
- 这项研究提出了第一个破坏癌细胞内在保护机制的策略,
- 自在热治疗中起着至关重要的调节作用,突出显示其作为治疗点的重要性.
- 开发的纳米调节器平台通过调节热致死提供了高效和安全的癌症治疗方法.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


